Dr. Puscheck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
InVia Fertility
1585 Barrington Road, Ste 406
Hoffman Estates, IL 60169Phone+1 847-884-8884Fax+1 847-884-0924
Education & Training
- University of TennesseeM.B.A., 2016 - 2016
- Medical College of GeorgiaFellowship, Reproductive Endocrinology and Infertility, 1991 - 1993
- Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 1987 - 1991
- Washington University in St. Louis School of MedicineClass of 1987
- University of ChicagoM.S., Arts and Sciences Basic to Human Biology, 1983 - 1985
- University of ChicagoA.B., Biology and Anthropology, Honors, 1979 - 1983
Certifications & Licensure
- IL State Medical License 1993 - 2026
- CA State Medical License 1994 - 2025
- MI State Medical License 2000 - 2025
- GA State Medical License 1991 - 1993
- PA State Medical License 1990 - 1992
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- A Single Cell Transcriptomic Fingerprint of Stressed Premature, Imbalanced Differentiation of Embryonic Stem Cells.Ximena L Ruden, Aditi Singh, Teya Marben, Wen Tang, Awoniyi O Awonuga
Birth Defects Research. 2024-11-01 - 2 citationsDeterminants of Embryo Implantation: Roles of the Endometrium and Embryo in Implantation Success.Awoniyi O Awonuga, Olivia G Camp, Husam M Abu-Soud, Daniel A Rappolee, Elizabeth E Puscheck
Reproductive Sciences. 2023-08-01 - Endoplasmic reticulum stress response and the regulation of endometrial interferon-beta production.Ramya Sethuram, Melissa Bukowski, Francis Hernandez, Yuan You, Elizabeth Puscheck
F&S Science. 2023-05-01
Authored Content
- Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020
- Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020
- Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020
Press Mentions
- Research Finds Stress Reduces Viral Resistance Against COVID-19 in Embryonic Stem CellsAugust 10th, 2021
- AIUM Practice Parameter for the Performance of a Focused Ultrasound Examination in Reproductive Endocrinology and Female InfertilityFebruary 13th, 2019
Grant Support
- A phase 3 study to evaluate the safety and efficacy of Elagolix in combination with Estradiol/Northindrone Acetate in Subjects with Moderate Endometriosis.AbbVie2016–2023
- A Randomized, double-blind, double-dummy, trial comparing MENOPUR solution for injection in a pre-filled pen and MENOPUR Powder and solvent for solution for injection (Menotropins for injection) in aFerring Pharmaceuticals2019–2021
- A Randomized, double-blind, placebo-controlled, parallel groups, multicenter trial investigating the efficacy and safety of FE999049 in controlled ovarian stimulation in women aged 34-42 years undergoFerring Pharmaceuticals2018–2021
- A Randomized, double-blind, placebo-controlled, parallel groups, multicenter trial investigating the efficacy and safety of FE999049 in controlled ovarian stimulation in women aged 18-34 years undergoFerring Pharmaceuticals2018–2021
- Extension study to evaluate the efficacy and safety of Elagolix in premenopausal women with heavy menstrual bleeding associated with uterine fibroids.Abbvie2017–2020
- A Phase 3, multicenter, randomized, double-blind, placebo-controlled study, investigating the efficacy and safety of daily oral administration of InvDrug alone and in combination with add-back therapyObseva2017–2020
- WSU Cooperative Reproductive Medicine Network CenterNICHD2007–2019
- Detroit Reproductive Career Development Research Center (WRHR)NIH/NICHD2011–2016
Committees
- Gynecology Community Leader (Secretary- 2years, Vice Chair- 2years, then Chair -2 years), American Institute of Ultrasound in Medicine 2020 - Present
Professional Memberships
- Fellow
- Member
- Member
- Society of Reproductive Endocrine and InfertilityMember
- Society of Assisted Reproductive TechnologyMember
- Endocrine SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: